Explore Business Standard
The Foreign Investment and Promotion Board (FIPB) has deferred Gland Pharma's - Shanghai Fosun deal worth $ 1.4 billion.It approved nine investment proposals, including those of Netmagic Solutions and Vodafone, totaling a foreign investment of Rs 659 crore. The inter-ministerial body, to be wound up soon, recommended to the Cabinet Committee on Economic Affairs a proposal by Apollo Hospitals to raise fresh equity shares for Rs 750 Crores through foreign investment. China's Shanghai Fosun planned to acquire 86% stake in India's Gland Pharmacueticals last year in July. Gland Pharma is a Hyderabad-based pharmaceutical company and is a specialist in injectable. This deal would boost the company's presence in Africa, Europe and Japan.This was the first deal in the pharmaceutical sector that was signed after the Centre eased FDI norms in May last year. The government had allowed inflow of upto 74% FDI in pharmaceutical companies through the automatic route.Fosun had worked out a clear-cut ..